Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.36 |
| ▸ | FDPS | P14324 | 5/20 | 0.36 |
| ▸ | LAP3 | P28838 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16696934 | 0.90 | LPAR3 (0.38) | SMPD1FDPSLAP3PLA2G2ALPAR3 | |
| SCHEMBL20580166 | 0.85 | SMPD1 (0.39) | SMPD1FDPSLAP3 | |
| SCHEMBL16697204 | 0.84 | FDPS (0.34) | SMPD1FDPSLAP3PLA2G2A | |
| SCHEMBL16697383 | 0.82 | FDPS (0.47) | SMPD1FDPSLAP3LPAR3LPAR2 | |
| SCHEMBL13924959 | 0.77 | GPR84 (0.47) | SMPD1FDPSLAP3GPR84FFAR1 | |
| SCHEMBL5326687 | 0.77 | GPR84 (0.47) | SMPD1FDPSLAP3GPR84FFAR1 | |
| SCHEMBL2940140 | 0.77 | SMPD1 (0.43) | SMPD1FDPSLAP3PLA2G2ALPAR3 | |
| SCHEMBL4229201 | 0.77 | GPR84 (0.47) | SMPD1FDPSLAP3GPR84FFAR1 | |
| SCHEMBL3107682 | 0.76 | SMPD1 (0.42) | SMPD1FDPSLAP3PLA2G2ALPAR3 | |
| SCHEMBL9234014 | 0.76 | SMPD1 (0.42) | SMPD1FDPSLAP3PLA2G2ALPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190218643-A1 | NEW EXTRACTANT, USEFUL FOR EXTRACTING RARE EARTHS FROM AN AQUEOUS PHOSPHORIC ACID SOLUTION, AND THE APPLICATIONS THEREOF | UNIVERSITE DE MONTPELLIER (FR) | 2019-07-18 | — | — | US | claimed |
| US-20180355457-A1 | METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM PRESENT IN AN AQUEOUS SOLUTION INCLUDING PHOSPHORIC ACID | Orano Mining (FR) | 2018-12-13 | — | — | US | claimed |
| US-9441285-B2 | Bifunctional compounds useful as ligands of uranium (VI), methods of synthesising same and uses thereof | AREVA MINES (FR) | 2016-09-13 | — | — | US | claimed |
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | AREVA MINES (FR) | 2015-05-14 | — | — | US | claimed |
| US-20190218643-A1 | NEW EXTRACTANT, USEFUL FOR EXTRACTING RARE EARTHS FROM AN AQUEOUS PHOSPHORIC ACID SOLUTION, AND THE APPLICATIONS THEREOF | UNIVERSITE DE MONTPELLIER (FR) | 2019-07-18 | — | — | US | disclosed |
| US-20180355457-A1 | METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM PRESENT IN AN AQUEOUS SOLUTION INCLUDING PHOSPHORIC ACID | Orano Mining (FR) | 2018-12-13 | — | — | US | disclosed |
| US-20180187290-A1 | METHOD FOR SEPARATING IRON FROM AN ORGANIC PHASE CONTAINING URANIUM AND METHOD FOR EXTRACTING URANIUM FROM AN AQUEOUS SOLUTION OF MINERAL ACID CONTAINING URANIUM AND IRON | AREVA MINES (FR) | 2018-07-05 | — | — | US | disclosed |
| US-9441285-B2 | Bifunctional compounds useful as ligands of uranium (VI), methods of synthesising same and uses thereof | AREVA MINES (FR) | 2016-09-13 | — | — | US | disclosed |
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | AREVA MINES (FR) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | URB2, CHRM2, C1S | SMPD1 4274/4885FDPS 2645/4885LAP3 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.